Virological aspects of Epstein-Barr virus infections

Acta Medica Okayama

Volumn 59, Issue 6, 2005, Pages 239-246

  Yamashita, Nobuko ^a   Kimura, Hiroshi ^b   Morishima, Tsuneo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic active Epstein Barr virus infection; Epstein Barr virus associated hemophagocytic syndrome; Real time PCR; Tetramer

Indexed keywords

VIRUS DNA;

CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNOLOGY; INFECTIOUS MONONUCLEOSIS; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; REVIEW; VIROLOGY; VIRUS INFECTION;

DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN HERPESVIRUS 4;

EID: 31344478710     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y and Koizumi S: Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood (2001) 98: 1882-1888.
2. + T cells in patients with chronic active EBV infection. J Infect Dis (2004) 190: 985-988.
3. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T and Morishima T: Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol (1999) 37: 132-136.
4. Kimura H, Hoshino Y, Hara S, Nishikawa K, Sako M, Hirayama M, Komada Y and Morishima T: Viral load in Epstein-Barr virus-associated hemophagocytic syndrome. Microbiol Immunol (2002) 46: 579-582.
5. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ and Davis MM: Phenotypic analysis of antigen-specific T lymphocytes. Science (1996) 274: 94-96.
6. Weinberger B, Plentz A, Weinberger K M, Hahn J, Holler E and Jilg W: Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCR. J Med Virol (2004) 74: 612-618.
7. Stevens SJ, Pronk I and Middeldorp JM: Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol (2001) 39: 1211-1216.
8. Kudo T, Egawa H, Kuzushima K, Kimura H, Morishima T and lchiyama S: Diagnostic testing in Epstein-Barr virus infection. Clin Chem Lab Med (2001) 39: 789-794.
9. Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, Maccario R, Fiocchi R and Gerna G: High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol (2000) 38: 613-619.
10. Jabs WJ, Hennig H, Kittel M, Pethig K, Smets F, Bucsky P, Kirchner H and Wagner HJ: Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders. J Clin Microbiol (2001) 39: 564-569.
11. Kimura H, Nishikawa K, Hoshino Y, Sofue A, Nishiyama Y and Morishima T: Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol (Berl) (2000) 188: 197-202.
12. Berger C, Day P, Meier G, Zingg W, Bossart W and Nadal D: Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol (2001) 64: 505-512.
13. Kanegane H, Wakiguchi H, Kanegane C, Kurashige T, Miyawaki T and Tosato G: Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection. Clin Infect Dis (1999) 28: 906-909.
14. Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa S, Kuzushima K, Shibata M and Morishima T: Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol (1995) 33: 1765-1768.
15. + T cells. Blood (2003) 101: 1460-1468.
16. Date Y, Kimura A, Kato H and Sasazuki T: DNA typing of the HLA-A gene: population study and identification of four new alleles in Japanese. Tissue Antigens (1996) 47: 93-101.
17. Saito S, Ota S, Yamada E, Inoko H and Ota M: Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens (2000) 56: 522-529.
18. Kasahara Y and Yachie A: Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol (2002) 44: 283-294.
19. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S and Tawa A: Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood (1997) 89: 4100-4103.
20. Ohga S, Nomura A, Takada H and Hara T: Immunological aspects of Epstein-Barr virus infection. Crit Rev Oncol Hematol (2002) 44: 203-215.
21. Mizuno S, Akashi K, Ohshima K, Iwasaki H, Miyamoto T, Uchida N, Shibuya T, Harada M, Kikuchi M and Niho Y: Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood (1999) 93: 3494-3504.
22. Morrison TE, Mauser A, Klingelhutz A and Kenney SC: Epstein-Barr virus immediate-early protein BZLFI inhibits tumor necrosis factor alpha-induced signaling and apoptosis by down regulating tumor necrosis factor receptor 1. J Virol (2004) 78: 544-549.
23. Garcia-Ruiz C, Colell A, Mari M, Morales A, Calvo M, Enrich C and Fernandez-Checa JC: Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest (2003) 111: 197-208.
24. Kimura H, Nagasaka T, Hoshino Y, Hayashi N, Tanaka N, Xu JL, Kuzushima K and Morishima T: Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol (2001) 32: 757-762.
25. Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, Kinukawa N, Ohshima K, Kohno K, Kurimoto M and Hara T: Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol (1999) 106: 182-189.
26. Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K and Morishima T: Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis (2005) 191: 531-539.
27. Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N and Hara T: Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis (2001) 183: 1-7.
28. Vicari AP and Trinchieri G: Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunol Rev (2004) 202: 223-236.
29. Iwatsuki K, Yamamoto T, Tsuji K, Suzuki D, Fujii K, Matsuura H and Oono T: A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections. Acta Med Okayama (2004) 58: 169-180.
30. Kanegane H, Wakiguchi H, Kanegane C, Kurashige T and Tosato G: Viral interleukin-10 in chronic active Epstein-Barr virus infection. J Infect Dis (1997) 176: 254-257.
31. Helminen ME, Kilpinen S, Virta M and Hurme M: Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis (2001) 184: 777-780.
32. Jones JF and Straus SE: Chronic Epstein-Barr virus infection. Annu Rev Med (1987) 38: 195-209.
33. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K and Kawa-Ha K: Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol (1997) 54: 276-281.
34. Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H and Kaneko F: The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol (1999) 140: 715-721.
35. Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K and Matsuoka H: Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol (1999) 115: 385-392.
36. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K and Morishima T: Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood (2001) 98: 280-286.
37. Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K and Wakiguchi H: Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis (2003) 187: 527-533.
38. Morishima T and Kuzushima K: Adoptive immune therapy for EBV-associated lymphoproliferative disorders; in Gann Monograph on Cancer Research, Osato T, Takada K and Tokunaga M eds, Japan Scientific Societies Press, Tokyo (1998) 45: 175-185.
39. Heslop HE, Brenner MK and Rooney CM: Donor T cells to treat EBV-associated lymphoma. N Engl J Med (1994) 331: 679-680.
40. Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P and Fournie JJ: Acquisition of viral receptor by NK cells through immunological synapse. J Immunol (2003) 170: 5993-5998.
41. Ueda I, Morimoto A, Inaba T, Yagi T, Hibi S, Sugimoto T, Sako M, Yanai F, Fukushima T, Nakayama M, Ishii E and Imashuku S: Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol (2003) 121: 503-510.
42. Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, Dale JK, Straus SE and Cohen JI: Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood (2004) 103: 1244-1252.
43. Morita M, Tsuge I, Matsuoka H, Ito Y, Itosu T, Yamamoto M and Morishima T: Calcification in the basal ganglia with chronic active Epstein-Barr virus infection. Neurology (1998) 50: 1485-1488.
44. Morishima T, Morita M, Kato T, Hoshino Y and Kimura H: Natural killer cell proliferation and circulating cytokines in patients with bilateral basal ganglia calcification. Eur J Neurol (2002) 9: 521-525.